$MED
MEDIFAST INC

2018 Q1 Form 10-K Financial Statement

#000114420419011678 Filed on March 01, 2019

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q3
Revenue $98.60M $78.01M $77.21M
YoY Change 39.61% 24.81% 12.54%
Cost Of Revenue $23.80M $18.90M $19.02M
YoY Change 34.46% 22.73% 15.99%
Gross Profit $74.81M $59.13M $58.18M
YoY Change 41.44% 25.53% 11.46%
Gross Profit Margin 75.87% 75.8% 75.36%
Selling, General & Admin $59.70M $49.60M $47.96M
YoY Change 34.76% 22.47% 11.01%
% of Gross Profit 79.8% 83.89% 82.42%
Research & Development $400.0K
YoY Change
% of Gross Profit 0.53%
Depreciation & Amortization $1.500M $1.000M $1.100M
YoY Change 36.36% -16.67% -8.33%
% of Gross Profit 2.01% 1.69% 1.89%
Operating Expenses $60.10M $49.60M $47.96M
YoY Change 35.67% 22.47% 11.01%
Operating Profit $14.71M $9.526M $10.23M
YoY Change 71.18% 44.33% 13.63%
Interest Expense $200.0K $200.0K $148.0K
YoY Change 100.0% 48.0%
% of Operating Profit 1.36% 2.1% 1.45%
Other Income/Expense, Net $0.00 $100.0K $144.0K
YoY Change
Pretax Income $14.93M $9.796M $10.37M
YoY Change 71.4% 46.21% 15.23%
Income Tax $2.700M $2.100M $3.685M
% Of Pretax Income 18.08% 21.44% 35.53%
Net Earnings $12.22M $7.306M $6.686M
YoY Change 98.89% 78.2% 9.61%
Net Earnings / Revenue 12.4% 9.37% 8.66%
Basic Earnings Per Share $1.02 $0.61 $0.56
Diluted Earnings Per Share $1.01 $0.60 $0.55
COMMON SHARES
Basic Shares Outstanding 11.93M
Diluted Shares Outstanding 12.10M

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $109.2M $173.9M $95.70M
YoY Change 38.23% 126.45% 16.57%
Cash & Equivalents $87.00M $75.08M $70.55M
Short-Term Investments $22.30M $98.83M $25.20M
Other Short-Term Assets $3.600M $4.200M $2.400M
YoY Change 24.14% 20.0% -51.02%
Inventory $20.23M $19.33M $16.00M
Prepaid Expenses
Receivables $1.133M $576.0K $700.0K
Other Receivables $0.00 $2.200M $500.0K
Total Short-Term Assets $131.1M $125.2M $115.3M
YoY Change 26.54% 23.59% 11.72%
LONG-TERM ASSETS
Property, Plant & Equipment $18.40M $18.61M $18.80M
YoY Change -3.66% -6.01% -6.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.300M $2.120M $400.0K
YoY Change 1050.0% 960.0% 100.0%
Total Long-Term Assets $20.70M $20.73M $19.20M
YoY Change 7.25% 4.18% -5.42%
TOTAL ASSETS
Total Short-Term Assets $131.1M $125.2M $115.3M
Total Long-Term Assets $20.70M $20.73M $19.20M
Total Assets $151.8M $145.9M $134.5M
YoY Change 23.52% 20.4% 8.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.20M $37.10M $26.30M
YoY Change 64.66% 52.67% 7.79%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $38.20M $37.14M $26.30M
YoY Change 64.66% 52.21% 1.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $38.20M $37.14M $26.30M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $38.20M $37.35M $26.30M
YoY Change 60.5% 48.21% -7.72%
SHAREHOLDERS EQUITY
Retained Earnings $101.7M $103.8M
YoY Change
Common Stock $12.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $113.6M $106.6M $108.2M
YoY Change
Total Liabilities & Shareholders Equity $151.8M $145.9M $134.5M
YoY Change 23.52% 20.4% 8.91%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income $12.22M $7.306M $6.686M
YoY Change 98.89% 78.2% 9.61%
Depreciation, Depletion And Amortization $1.500M $1.000M $1.100M
YoY Change 36.36% -16.67% -8.33%
Cash From Operating Activities $18.00M $9.900M $12.60M
YoY Change 168.66% -3400.0% 80.0%
INVESTING ACTIVITIES
Capital Expenditures -$1.300M -$800.0K -$1.400M
YoY Change 160.0% -11.11% 16.67%
Acquisitions
YoY Change
Other Investing Activities $1.200M $1.100M -$300.0K
YoY Change -340.0% -92.86%
Cash From Investing Activities -$100.0K $200.0K -$1.700M
YoY Change -90.0% -125.0% -68.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.000M -5.600M -3.900M
YoY Change 46.34% 60.0% 30.0%
NET CHANGE
Cash From Operating Activities 18.00M 9.900M 12.60M
Cash From Investing Activities -100.0K 200.0K -1.700M
Cash From Financing Activities -6.000M -5.600M -3.900M
Net Change In Cash 11.90M 4.500M 7.000M
YoY Change 643.75% -197.83% -600.0%
FREE CASH FLOW
Cash From Operating Activities $18.00M $9.900M $12.60M
Capital Expenditures -$1.300M -$800.0K -$1.400M
Free Cash Flow $19.30M $10.70M $14.00M
YoY Change 168.06% 1683.33% 70.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0000910329
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11870444
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q2 dei Entity Public Float
EntityPublicFloat
1800000000
CY2018 dei Entity Registrant Name
EntityRegistrantName
MEDIFAST INC
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2017Q4 med Deferred Tax Liabilities Depreciations
DeferredTaxLiabilitiesDepreciations
2165000
CY2018Q4 med Deferred Tax Liabilities Depreciations
DeferredTaxLiabilitiesDepreciations
1199000
CY2017Q4 med Deferred Tax Liability Accrued Expenses And Deferred Costs
DeferredTaxLiabilityAccruedExpensesAndDeferredCosts
642000
CY2018Q4 med Deferred Tax Liability Accrued Expenses And Deferred Costs
DeferredTaxLiabilityAccruedExpensesAndDeferredCosts
2473000
CY2018 med Estimated Tax Act Impact On Earnings Per Common Share
EstimatedTaxActImpactOnEarningsPerCommonShare
0.04
CY2017Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
920000
CY2018Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
2391000
CY2017Q4 med Promotional Sales Incentive Accruals
PromotionalSalesIncentiveAccruals
1934000
CY2018Q4 med Promotional Sales Incentive Accruals
PromotionalSalesIncentiveAccruals
3817000
CY2018 med Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
426000
CY2016 med Unrealized Gain Loss On Investment Securities And Foreign Currency Income Tax Effects Allocated To Equity
UnrealizedGainLossOnInvestmentSecuritiesAndForeignCurrencyIncomeTaxEffectsAllocatedToEquity
74000
CY2017 med Unrealized Gain Loss On Investment Securities And Foreign Currency Income Tax Effects Allocated To Equity
UnrealizedGainLossOnInvestmentSecuritiesAndForeignCurrencyIncomeTaxEffectsAllocatedToEquity
-52000
CY2018 med Unrealized Gain Loss On Investment Securities And Foreign Currency Income Tax Effects Allocated To Equity
UnrealizedGainLossOnInvestmentSecuritiesAndForeignCurrencyIncomeTaxEffectsAllocatedToEquity
-43000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37140000
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
41277000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
60323000
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
13797000
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
21814000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
576000
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1133000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1011000
CY2017Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
417000
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5546000
CY2017Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
7707000
CY2018Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
8309000
CY2017Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6584000
CY2018Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
10626000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33458000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34714000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-160000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-171000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-160000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-173000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4967000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8802000
CY2016 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1342000
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2540000
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
720000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
3428000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
4267000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
3124000
CY2016 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
230000
CY2016 us-gaap Advertising Expense
AdvertisingExpense
9400000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
7700000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
6000000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
40000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
394000
CY2017Q4 us-gaap Assets
Assets
145929000
CY2018Q4 us-gaap Assets
Assets
169429000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
125198000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
145519000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
98823000
CY2018Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
100990000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
268000
CY2018Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
236000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
98834000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
101034000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12103000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12117000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11971000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11868000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42037000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52436000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75077000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81364000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10399000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22641000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6287000
CY2016 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-640000
CY2016 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.07
CY2017 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.44
CY2018 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.19
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17732000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27726000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
55776000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
16398000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
12116000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13228000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17446000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:6pt 0pt;text-align:left;font-family:Courier New;text-justify:inter-ideograph;font-size: 9pt"> <font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:9pt;">Concentration of Credit Risk</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"> &#x2013; Our cash and cash equivalents and available-for-sale securities are maintained at several financial institutions, and the balances with these financial institutions often exceed the amount of insurance provided on such accounts by the Federal Deposit Insurance Corporation. The cash and cash equivalents generally are maintained with financial institutions with reputable credit, and therefore bear minimal credit risk. Historically, we have not experienced any losses due to such concentration of credit risk. </font> </p> <p><font size="1"> </font></p> </div> </div>
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
68870000
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
73751000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
121104000
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-2018000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11605000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
12448000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
511000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
780000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1048000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3078000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-667000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2393000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-4000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
107000
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-205000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2829000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-623000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2687000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2832000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1973000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
253000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-63000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-89000
CY2017Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
494000
CY2018Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
681000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2624000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4953000
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
229000
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
275000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2980000
CY2018Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
336000
CY2018Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2980000
CY2018Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2980000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
952000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
812000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
233000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
647000
CY2017Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
74000
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2018Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
65000
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
208000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
208000
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
667000
CY2018Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
774000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5405000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4209000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4435000
CY2016 us-gaap Dividends Cash
DividendsCash
4039000
CY2017 us-gaap Dividends Cash
DividendsCash
6105000
CY2018 us-gaap Dividends Cash
DividendsCash
9137000
CY2016 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12915000
CY2017 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17456000
CY2018 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
26189000
CY2017Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
6105000
CY2018Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
9137000
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.51
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.67
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.17
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.32
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.49
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.29
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.62
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.30
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.006
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
0.034
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
0.022
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.002
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.003
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.002
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.004
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.008
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.030
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.026
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.008
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.004
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.029
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.342
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.313
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.209
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.006
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.001
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7000
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-71000
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
230000
CY2016 us-gaap Equipment Expense
EquipmentExpense
700000
CY2017 us-gaap Equipment Expense
EquipmentExpense
200000
CY2018 us-gaap Equipment Expense
EquipmentExpense
100000
CY2016 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
230000
CY2016 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
118000
CY2017 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-82000
CY2018 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-3000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
12000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-94000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48000
CY2016 us-gaap Gross Profit
GrossProfit
205664000
CY2017Q1 us-gaap Gross Profit
GrossProfit
52892000
CY2017 us-gaap Gross Profit
GrossProfit
227812000
CY2017Q2 us-gaap Gross Profit
GrossProfit
57611000
CY2017Q3 us-gaap Gross Profit
GrossProfit
58183000
CY2017Q4 us-gaap Gross Profit
GrossProfit
59126000
CY2018Q1 us-gaap Gross Profit
GrossProfit
74808000
CY2018 us-gaap Gross Profit
GrossProfit
379899000
CY2018Q2 us-gaap Gross Profit
GrossProfit
88799000
CY2018Q3 us-gaap Gross Profit
GrossProfit
107201000
CY2018Q4 us-gaap Gross Profit
GrossProfit
109091000
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
6083000
CY2016Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
6100000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17619000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17828000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20170000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
11615000
CY2016 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
920000
CY2017 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
870000
CY2016 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
17835000
CY2017 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
27721000
CY2018 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
55789000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27122000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8711000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40326000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11448000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10371000
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9796000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14931000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
70548000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
13622000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
14606000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9287000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12605000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14759000
CY2016 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
8983000
CY2017 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
12657000
CY2018 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
14802000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-222000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-77000
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
174000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9493000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14114000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14815000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
41000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
147000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
615000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-1191000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-1852000
CY2016 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
36000
CY2017 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
258000
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
323000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
797000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
446000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
769000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
163000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
85000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
770000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10653000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16017000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-246000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-815000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-122000
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
300000
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1023000
CY2018 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2272000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4976000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1017000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18658000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-43000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1958000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-62000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
616000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
686000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
282000
CY2016 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
283000
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
558000
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1306000
CY2017Q4 us-gaap Interest Receivable
InterestReceivable
279000
CY2018Q4 us-gaap Interest Receivable
InterestReceivable
280000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13407000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25509000
CY2017Q4 us-gaap Inventory Net
InventoryNet
19328000
CY2018Q1 us-gaap Inventory Net
InventoryNet
20230000
CY2018Q4 us-gaap Inventory Net
InventoryNet
38888000
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4348000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
11156000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
532000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1731000
CY2017Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
23757000
CY2018Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
19670000
CY2017Q4 us-gaap Liabilities
Liabilities
37348000
CY2018Q4 us-gaap Liabilities
Liabilities
60323000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145929000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
169429000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37140000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60323000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12921000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17362000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53328000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2037000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3163000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1199000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25350000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43237000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60816000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
25990000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
43237000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
60816000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
17835000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
6145000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
27721000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
7584000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
6686000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
7306000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
12222000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
55789000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
14133000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
13781000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
15653000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
263000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
694000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1485000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
26859000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
39632000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
69063000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9545000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1496000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1155000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1222000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1562000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1528000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2582000
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
21400000
CY2016 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
431000
CY2017 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
703000
CY2018 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
571000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2120000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1183000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-110000
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
76000
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-11000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-71000
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-103000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-65000
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-11000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-175000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
65000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
136000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
179000
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29995000
CY2016 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
1342000
CY2017 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
2540000
CY2018 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
720000
CY2016 us-gaap Payments Of Dividends
PaymentsOfDividends
11889000
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
15390000
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
23160000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
26578000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6956000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2876000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3242000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4940000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4188000
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4304000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4586000
CY2017Q4 us-gaap Prepaid Taxes
PrepaidTaxes
2272000
CY2018 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:6pt 0pt;text-align:left;font-family:Courier New;text-justify:inter-ideograph;font-size: 9pt"> <font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:9pt;">Reclassification</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"> &#x2013; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation.&nbsp;&nbsp;No reclassification in the consolidated financial statements had a material impact on the presentation.</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
676000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
81000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
196000
CY2016 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
26741000
CY2017 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
6954000
CY2018 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3545000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
299000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
568000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
547000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52069000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54461000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18611000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19747000
CY2016 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
118000
CY2017 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-82000
CY2018 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-3000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
219000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1500000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2200000
CY2017Q4 us-gaap Retail Related Inventory
RetailRelatedInventory
1185000
CY2018Q4 us-gaap Retail Related Inventory
RetailRelatedInventory
1563000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
103762000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
101744000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131344000
CY2016 us-gaap Revenues
Revenues
274534000
CY2017Q1 us-gaap Revenues
Revenues
70622000
CY2017 us-gaap Revenues
Revenues
301563000
CY2017Q2 us-gaap Revenues
Revenues
75729000
CY2017Q3 us-gaap Revenues
Revenues
77205000
CY2017Q4 us-gaap Revenues
Revenues
78007000
CY2018Q1 us-gaap Revenues
Revenues
98596000
CY2018 us-gaap Revenues
Revenues
501003000
CY2018Q2 us-gaap Revenues
Revenues
117324000
CY2018Q3 us-gaap Revenues
Revenues
139239000
CY2018Q4 us-gaap Revenues
Revenues
145844000
CY2017Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
596000
CY2018Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1074000
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
157.30
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
23757000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
19670000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
178805000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
188180000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
310836000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3428000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
4267000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
3124000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0356
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0240
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0287
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4222
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3833
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3330
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0111
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0205
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0264
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
600000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1600000
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
26.52
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
88584000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
96016000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
108581000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109106000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
299000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
568000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
547000
CY2018 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
182750
CY2017Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
850000
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
193000
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
30879000
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
29995000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:6pt 0pt;text-align:left;font-family:Courier New;text-justify:inter-ideograph;font-size: 9pt"> <font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:9pt;">Use of Estimates</font><font style="display: inline;font-family:Times New Roman;font-size:9pt;"> &#x2013; The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates. </font> </p> <p><font size="1"> </font></p> </div> </div>
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
105000
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
164000
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
132000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11947000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12088000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12079000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11842000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11924000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11947000

Files In Submission

Name View Source Status
0001144204-19-011678-index-headers.html Edgar Link pending
0001144204-19-011678-index.html Edgar Link pending
0001144204-19-011678.txt Edgar Link pending
0001144204-19-011678-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
med-20181231.xml Edgar Link completed
med-20181231.xsd Edgar Link pending
med-20181231_cal.xml Edgar Link unprocessable
med-20181231_def.xml Edgar Link unprocessable
med-20181231_lab.xml Edgar Link unprocessable
med-20181231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv508957_10k.htm Edgar Link pending
tv508957_10kimg01.jpg Edgar Link pending
tv508957_ex10-10.htm Edgar Link pending
tv508957_ex10-11.htm Edgar Link pending
tv508957_ex10-8.htm Edgar Link pending
tv508957_ex10-9.htm Edgar Link pending
tv508957_ex21-1.htm Edgar Link pending
tv508957_ex23-1.htm Edgar Link pending
tv508957_ex31-1.htm Edgar Link pending
tv508957_ex31-2.htm Edgar Link pending
tv508957_ex32.htm Edgar Link pending